Sponsored by an educational grant from Ipsen
As a general overview, I think as he said in his conclusion, there is little doubt that LOH has a significant impact on different organs.
There is a clear impact of low testosterone on many important functions. We have seen the impact on the cognitive function, on the brain, mood, depression, overall wellness, bone and bone mineral density, on the (inaudible), on sexual function. It is obvious that a significant percentage of patients, as Dr. Morgentaler said, are not diagnosed for what is really the cause of their sexual function, even in recommendation from the AUA, another big scientific society, it is not recommended to use testosterone in patients with ED, you just write out a prescription and the patients walks out and you may treat people for a year or so with PDE-5 successfully while they don’t need essentially PDE-5 and they might benefit much more from having their testosterone up and get rid of PDE-5 and some of the side effects.
At the end, of course we need to, I would say, reconsider a lot of our historical information about testosterone and what I mentioned earlier about this completely hysterical false concept about the negative input on the prostate and prostate cancer that is completely hysterical and probably a misconcept. So there are many things that are still, I would say, under-informed we need more information, the medical profession needs more information and definitely for this reason, a society like ISSAM is of great importance. It is important because it delivers the message that we all believe in. So to those people attending this conference here, they know most of the message. The message that is important is outside this conference. So, thank you again for your attention and again, come tomorrow morning for the important information that will be given by the Massachusetts Male Study.
Thank you again.